Table 11.6b

Immunosuppression Use for Induction by Discharge Regimen, 2002 to 2006

Recipients with Heart Transplants

  Discharge Regimen (w/ or w/o Steroids Use) All
CyA Tac CyA+ MMF Tac+ MMF CyA+ Aza Tac+ Aza Siro+ MMF CyA+ Siro Tac+ Siro Other
Functioning Graft with Immunosuppression Info at Discharge 140 275 3,644 3,752 407 122 91 63 211 902 9,607
% of All Regimens 1.5% 2.9% 37.9% 39.1% 4.2% 1.3% 0.9% 0.7% 2.2% 9.4% 100.0%
Induction Drug 9.3% 7.3% 7.1% 4.7% 6.9% 11.5% 6.6% 4.8% 5.2% 18.1% 7.2%
Atgam/NRATG/NRATS
OKT3 4.3% 1.8% 3.7% 2.2% 19.4% 4.9% 2.2% 0.0% 4.7% 9.3% 4.3%
Thymoglobulin 5.7% 9.5% 13.3% 17.6% 19.4% 27.9% 22.0% 3.2% 23.7% 25.3% 16.6%
Zenapax 3.6% 1.1% 18.6% 10.6% 3.2% 2.5% 12.1% 77.8% 0.5% 34.8% 15.3%
Simulect 7.9% 9.8% 12.5% 12.3% 3.7% 2.5% 6.6% 4.8% 3.3% 16.2% 11.8%
Campath 0.0% 1.8% 0.0% 1.8% 0.0% 0.0% 4.4% 0.0% 0.0% 1.2% 0.9%
No Induction Drugs Recorded 71.4% 70.5% 46.8% 55.1% 49.4% 51.6% 47.3% 11.1% 63.5% 42.8% 51.0%


Source: OPTN/SRTR Data as of May 1, 2007.

Individual induction drug percentages will not necessarily add up to 100 percent, as patients may be prescribed more than one induction drug.

CyA: Cyclosporine; Tac: Tacrolimus; MMF: Include MMF(Mycophenolate Mofetil) and MPA(Mycophenolate Sodium); Aza: Azathioprine; Siro: Sirolimus.